Project Grant HT9425261E116
Award Date 7/1/26
Completion Date 6/30/30
Dollars Obligated $3.5M
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Boston, MA 02114, USA
Similar Awards
- Federal Project Grant Award Summary The Defense Health Agency (DHA) awarded Massachusetts General Hospital (MGH) a $1.35M Project Grant under the Military Medical Research and Development program (CFDA 12.420) effective July 1, 2025 through June 30, 2029. The award funds research investigating metabolites and metabolic pathways in relation to Crohn disease risk, with research activities conducted at MGH's Boston, Massachusetts location. This biomedical research initiative aligns with the DHA's...
- Federal Grant Award Summary The Defense Health Agency awarded Massachusetts General Hospital a $1.67M project grant under the Military Medical Research and Development program (CFDA 12.420) effective September 1, 2025 through August 31, 2029. The award funds development of machine learning-based individualized cardiovascular dose-response models with application to novel clinical decision support systems and population-based analysis. This research initiative represents translational work...
- Federal Project Grant Award Summary The Defense Health Agency (DHA) awarded Massachusetts General Hospital (MGH) $771,627 under the Military Medical Research and Development program (CFDA 12.420) to conduct research titled "Tune and Strike Targeting of Glioblastoma." The award, effective August 1, 2025 through July 31, 2027, supports advanced biomedical research aimed at developing innovative therapeutic approaches for glioblastoma, a critical health challenge relevant to military...
- Federal Grant Award Summary Massachusetts General Hospital (MGH), operating under The General Hospital Corporation, received a $1.18M project grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) effective September 1, 2025, through August 31, 2028. The award supports "Enhancing Precision Oncology for Underserved Breast Cancer Patients Through Deep Learning-Aided Histopathology Analysis," a research initiative designed to...
- Federal Grant Award Summary The Defense Health Agency (DHA) awarded Massachusetts General Hospital $992,302 through the Military Medical Research and Development program (CFDA 12.420) on September 15, 2025, to support a three-year research project titled "Targeting MHCII Ubiquitination to Induce Immune Regulation in Vascularized Composite Tissue Transplantation." The project, which concludes on September 14, 2028, focuses on advancing biomedical research aimed at transforming...
- Federal Grant Award Summary Massachusetts General Hospital (MGH) received a $165,000 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) effective September 1, 2025 through August 31, 2027. The award supports research mapping drug-sensitive gene expression profiles to spatial patterns of heterogeneity in a mouse model of schwannoma. This research initiative advances the Defense Health Agency's mission to transform healthcare...
- Federal Grant Award Summary Massachusetts General Hospital (MGH), doing business as The General Hospital Corporation, received a $1,385,292 Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420), effective August 15, 2025 through August 14, 2028. The grant supports research focused on ex vivo preservation for vascularized composite allotransplantation (VCA) with emphasis on making tolerance induction protocols clinically...
- Federal Project Grant Award Summary The Defense Health Agency (DHA), under the Military Medical Research and Development program (CFDA 12.420), awarded Massachusetts General Hospital a $1.27M Project Grant effective July 1, 2025 through June 30, 2029 to develop personalized cancer vaccines targeting tumor heterogeneity and reprogramming the cold tumor microenvironment in kidney cancer. This research initiative represents DHA's commitment to advancing biomedical solutions relevant to military...
- Federal Project Grant Award Summary The Defense Health Agency awarded Massachusetts General Hospital (MGH) a $382,381 Project Grant under the Military Medical Research and Development program (CFDA 12.420) effective September 1, 2025, through August 31, 2028. The award supports research on genetic immunodetection and treatment of vascularized composite allograft (VCA) rejection. MGH's Research Management Division, leveraging the institution's substantial biomedical research infrastructure and...
- Federal Project Grant Award Summary Massachusetts General Hospital (MGH), a leading academic medical center and teaching hospital of Harvard Medical School, received a $268,000 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) effective September 1, 2025, through August 31, 2027. The award funds the development and deployment of PDAC-PATHWAYS, a digital informational and supportive care application designed for patients...